Find a clinical trial


If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

Viewing Page 6 of 7 | Showing Results 26 - 30 of 35

BIP - Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab

The primary objective of this study is to assess the efficacy of Ocrelizumab (OCR) in Relapsing Multiple Sclerosis patients who have been...

Kyle E Smoot, M.D.
  • Providence St. Vincent Medical Center
  • St. Barnabas Medical Center
  • Swedish Medical Center

AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

Inclusion Criteria:-Age ≥ 45 years.-Clinical diagnosis of ischemic stroke + brain imaging to rule out hemorrhagic stroke.-Modified Rankin Scale...

Emily Ho, M.D.
  • Swedish Medical Center

A Phase 0/1 Study of Combination Drug Therapy For Glioblastoma Based on Personalized Cancer Stem Cell (CSC) High-Throughput Drug Screening (HTS)

A study to determine the safety of CSC/ HTS-based combination drug therapy in subjects who have GBM that has recurred or progressed following prior...

Charles Cobbs, M.D.
  • Swedish Medical Center

An Expanded Access Protocol for the Treatment of Glioblastoma Multiforme in Patients with Already Manufactured DCVax-L, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen Who Have Screen-Failed Protocol 020221

The study is an open-label expanded access study for patients for whom vaccine was manufactured during the Northwest Biotherapeutics' 020221...

Charles Cobbs, M.D.
  • Swedish Medical Center

A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine With Lomustine Compared to Lomustine Alone in Patients With AA That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy

Inclusion Criteria:Patients must meet all of the following inclusion criteria to be eligible for participation in this study:Surgical or...

Tara Benkers, M.D.
  • Swedish Medical Center
Viewing Page 6 of 7 | Showing Results 26 - 30 of 35